Cardiometabolic risk factors at baseline to 6 months, N (%) or mean (SD)
| Variable | Baseline for all participants (n=17) | Baseline for participants with follow-up data (n=9) | Six months (n=9) |
| Glycaemic status | |||
| Normoglycaemia | 1 (5.9%) | 0 (0%) | 5 (55.6%) |
| Isolated IGT | 3 (17.7%) | 3 (33.3%) | 2 (22.2%) |
| Isolated IFG | 7 (41.2%) | 3 (33.3%) | 1 (11.1%) |
| IGT+IFG | 6 (35.3%) | 3 (33.3%) | 1 (11.1%) |
| Type 2 diabetes mellitus | 0 | 0 | 0 |
| HbA1c (%)* | 5.8 (0.4) | 5.9 (0.5) | 5.7 (0.4) |
| Anthropometry | |||
| Normal weight BMI | 1 (5.9%) | 0 (0%) | 3 (33.3%) |
| Overweight BMI | 7 (41.2%) | 2 (22.2%) | 2 (22.2%) |
| Obese BMI | 9 (52.9%) | 7 (77.8%) | 4 (44.4%) |
| High waist circumference | 14 (82.4%) | 8 (88.9%) | 5 (55.6%) |
| BMI (kg/m2) | 28.9 (6.1) | 30.7 (5.1) | 26.2 (3.9) |
| Weight (kg) | 78.1 (13.8) | 80.3 (11.2) | 73.9 (14.8) |
| Waist circumference (cm) | 97.9 (10.9) | 99.7 (8.9) | 92.7 (12.0) |
| Abdominal sagittal circumference (cm) | 23.6 (6.4) | 25.6 (7.6) | 20.9 (5.2) |
| Other cardiometabolic markers | |||
| Systolic blood pressure (mm Hg) | 121.8 (9.8) | 124.3 (9.4) | 118.3 (14.2) |
| Diastolic blood pressure (mm Hg) | 78.8 (8.6) | 78.3 (8.8) | 77.1 (9.4) |
| Total cholesterol (mmol/l) | 4.8 (0.9) | 4.9 (1.0) | 4.4 (0.7) |
| LDL (mmol/L) | 3.3 (0.6) | 3.4 (0.8) | 3.0 (0.7) |
| HDL (mmol/L) | 1.0 (0.2) | 1.1 (0.3) | 1.0 (0.3) |
| Triglycerides (mmol/L) | 1.7 (0.7) | 1.5 (0.5) | 1.2 (0.5) |
*HbA1c cut-points are 5.7%–6.4%=pre-diabetes, 6.5% or greater=diabetes.
BMI, body mass index; HDL, high-density lipoprotein; IGT, impaired glucose tolerance; LDL, low-density lipoprotein.